Trifenagrel
Trifenagrel is an orally active platelet aggregation inhibitor that inhibits the inducing effects of arachidonic acid (AA) and collagen. The ED50s of trifenagrel for inhibiting AA- and collagen-induced platelet aggregation in guinea pigs were 1.4 mg/kg and 9.4 mg/kg, respectively[1].
Product Specifications
CAS Number
84203-09-8
UNSPSC
12352005
Target
COX
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/trifenagrel.html
Purity
99.35
Solubility
DMSO : 36 mg/mL (ultrasonic)
Smiles
CN(C)CCOC1=C(C=CC=C1)C2=NC(C3=CC=CC=C3)=C(C4=CC=CC=C4)N2
Molecular Formula
C25H25N3O
Molecular Weight
383.49
References & Citations
[1]Abrahams SL, et al. Trifenagrel: a chemically novel platelet aggregation inhibitor. J Pharmacol Exp Ther. 1989 May;249 (2) :359-65.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Ethyl 6-formylpyrazolo[1,5-a]pyrimidine-3-carboxylate](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Ethyl 6-formylpyrazolo[1,5-a]pyrimidine-3-carboxylate
Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) SLP2 Polyclonal Antibody
Rat Ankyrin repeat domain-containing protein 17 (ANKRD17) ELISA Kit
Rat Ankyrin repeat domain-containing protein 17 (ANKRD17) ELISA Kit
Rat Ankyrin repeat domain-containing protein 17 (ANKRD17) ELISA Kit